全球新生儿筛检市场规模、份额、趋势和成长分析报告（2026-2034年）

预计新生儿筛检市场将从 2025 年的 10.3425 亿美元成长到 2034 年的 20.9695 亿美元，2026 年至 2034 年的复合年增长率为 8.17%。

受人们对早期发现先天性和代谢性疾病重要性认识不断提高的推动，新生儿筛检市场正经历显着增长。随着医疗机构将预防性护理和早期疗育置于优先地位，对全面新生儿筛检计画的需求激增。串联式质谱质谱和基因检测等技术进步提高了筛检多种疾病的能力，从而能够及时诊断和治疗。随着家长和医疗专业人员认识到新生儿筛检在改善健康结果方面发挥的关键作用，预计这一趋势将进一步推动市场发展。

筛检调查方法和技术的创新正在塑造新生儿筛检市场的未来前景。非侵入性检测方法和就地检验方案的开发提高了筛检的可及性和便利性，使家庭能够更快地获得结果并进行后续护理。此外，资料管理和远端医疗解决方案的进步正在简化筛检流程，并促进医护人员与家庭之间的沟通。随着研究的进展和可透过新生儿筛检发现的新疾病的出现，筛检范围可能会扩大，涵盖更多疾病。

此外，增加对公共卫生政策和监管支持的投入，以加强筛检项目，将对新生儿筛检市场产生正面影响。医疗服务提供者、政策制定者和倡导团体之间的合作对于提高公众意识和确保全面的新生儿筛检服务至关重要。随着环境的变化，重点将转向将新生儿筛检纳入更广泛的妇幼保健策略，强调教育、后续护理和持续支持对于实现新生儿最佳健康状态的重要性。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球新生儿筛检市场：依产品划分

• 市场分析、洞察与预测
• 装置
• 试剂

第五章：全球新生儿筛检市场：依技术划分

• 市场分析、洞察与预测
• 串联式质谱质谱法
• 脉搏血氧计
• 基于酵素的检测
• DNA检测
• 电泳
• 其他的

第六章：全球新生儿筛检市场：按检测方法分類的展望

• 市场分析、洞察与预测
• 干血斑检查
• CCHD
• 听力筛检

第七章 全球新生儿筛检市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Covidien Plc
  • Masimo
  • Waters Corporation
  • Natus Medical
  • Trivitron Healthcare
  • GE Lifesciences
  • PerkinElmer Inc
  • AB SCIEX

The Newborn Screening Market size is expected to reach USD 2096.95 Million in 2034 from USD 1034.25 Million (2025) growing at a CAGR of 8.17% during 2026-2034.

The newborn screening market is experiencing significant growth, driven by the increasing awareness of the importance of early detection of congenital disorders and metabolic diseases. As healthcare providers prioritize preventive care and early intervention, the demand for comprehensive newborn screening programs is surging. Advances in technology, such as tandem mass spectrometry and genetic testing, are enhancing the ability to screen for a wide range of conditions, enabling timely diagnosis and treatment. This trend is expected to propel the market forward, as parents and healthcare professionals alike recognize the critical role of newborn screening in improving health outcomes.

Innovations in screening methodologies and technologies are shaping the future of the newborn screening market. The development of non-invasive testing methods and point-of-care testing solutions is improving accessibility and convenience for families, allowing for quicker results and follow-up care. Additionally, advancements in data management and telehealth solutions are streamlining the screening process, facilitating better communication between healthcare providers and families. As research continues to uncover new conditions that can be detected through newborn screening, the market is likely to witness the expansion of screening panels to include additional disorders.

Moreover, the newborn screening market will benefit from increased investment in public health initiatives and regulatory support aimed at enhancing screening programs. Collaborative efforts between healthcare providers, policymakers, and advocacy groups will be essential in promoting awareness and ensuring access to comprehensive newborn screening services. As the landscape evolves, the focus will increasingly shift towards integrating newborn screening into broader maternal and child health strategies, emphasizing the importance of education, follow-up care, and ongoing support in achieving optimal health outcomes for newborns.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents

By Technology

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assay
• DNA Assay
• Electrophoresis
• Others

By Test Type Outlook

• Dry Blood Spot Test
• CCHD
• Hearing Screen

COMPANIES PROFILED

• BioRad Laboratories, Agilent Technologies, Covidien plc, Masimo, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc, AB SCIEX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEWBORN SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEWBORN SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pulse Oximetry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Enzyme Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEWBORN SCREENING MARKET: BY TEST TYPE OUTLOOK 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type Outlook
• 6.2. Dry Blood Spot Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CCHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hearing Screen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEWBORN SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Technology
  • 7.2.3 By Test Type Outlook
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Technology
  • 7.3.3 By Test Type Outlook
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Technology
  • 7.4.3 By Test Type Outlook
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Technology
  • 7.5.3 By Test Type Outlook
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Technology
  • 7.6.3 By Test Type Outlook
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEWBORN SCREENING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bio-Rad Laboratories
  • 9.2.2 Agilent Technologies
  • 9.2.3 Covidien Plc
  • 9.2.4 Masimo
  • 9.2.5 Waters Corporation
  • 9.2.6 Natus Medical
  • 9.2.7 Trivitron Healthcare
  • 9.2.8 GE Lifesciences
  • 9.2.9 PerkinElmer Inc
  • 9.2.10 AB SCIEX